table of content
1 Study Coverage
1.1 End-Stage Renal Disease (ESRD) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Calcium Succinate
1.2.3 Mk-3866
1.2.4 Pacritinib
1.2.5 Sanguinate
1.2.6 Tesidolumab
1.2.7 Others
1.3 Market by Application
1.3.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ICU
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global End-Stage Renal Disease (ESRD) Drugs Sales by Region
2.4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2017-2022)
2.4.2 Global Sales End-Stage Renal Disease (ESRD) Drugs by Region (2023-2028)
2.5 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region
2.5.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2017-2022)
2.5.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers
3.1.1 Global Top End-Stage Renal Disease (ESRD) Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of End-Stage Renal Disease (ESRD) Drugs in 2021
3.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers
3.2.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by End-Stage Renal Disease (ESRD) Drugs Revenue in 2021
3.3 Global End-Stage Renal Disease (ESRD) Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global End-Stage Renal Disease (ESRD) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Type
4.1.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Sales by Type (2017-2022)
4.1.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
4.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type
4.2.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
4.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Type
4.3.1 Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2017-2022)
4.3.2 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Application
5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Sales by Application (2017-2022)
5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
5.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application
5.2.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
5.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Application
5.3.1 Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2017-2022)
5.3.2 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Type
6.1.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
6.1.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
6.2 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Application
6.2.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
6.2.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
6.3 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Country
6.3.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
6.3.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Type
7.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
7.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
7.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Application
7.2.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
7.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
7.3 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Country
7.3.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
7.3.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Type
8.1.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Application
8.2.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Region
8.3.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Type
9.1.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
9.1.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
9.2 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Application
9.2.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
9.2.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
9.3 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Country
9.3.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
9.3.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Type
10.1.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Application
10.2.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Country
10.3.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CTI BioPharma Corp
11.1.1 CTI BioPharma Corp Corporation Information
11.1.2 CTI BioPharma Corp Overview
11.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CTI BioPharma Corp Recent Developments
11.2 Merck & Co Inc
11.2.1 Merck & Co Inc Corporation Information
11.2.2 Merck & Co Inc Overview
11.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co Inc Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Prolong Pharmaceuticals LLC
11.4.1 Prolong Pharmaceuticals LLC Corporation Information
11.4.2 Prolong Pharmaceuticals LLC Overview
11.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Prolong Pharmaceuticals LLC Recent Developments
11.5 VESSL Therapeutics Ltd
11.5.1 VESSL Therapeutics Ltd Corporation Information
11.5.2 VESSL Therapeutics Ltd Overview
11.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 VESSL Therapeutics Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 End-Stage Renal Disease (ESRD) Drugs Industry Chain Analysis
12.2 End-Stage Renal Disease (ESRD) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 End-Stage Renal Disease (ESRD) Drugs Production Mode & Process
12.4 End-Stage Renal Disease (ESRD) Drugs Sales and Marketing
12.4.1 End-Stage Renal Disease (ESRD) Drugs Sales Channels
12.4.2 End-Stage Renal Disease (ESRD) Drugs Distributors
12.5 End-Stage Renal Disease (ESRD) Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 End-Stage Renal Disease (ESRD) Drugs Industry Trends
13.2 End-Stage Renal Disease (ESRD) Drugs Market Drivers
13.3 End-Stage Renal Disease (ESRD) Drugs Market Challenges
13.4 End-Stage Renal Disease (ESRD) Drugs Market Restraints
14 Key Findings in The Global End-Stage Renal Disease (ESRD) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
